Real-time glucose monitoring for type 2 diabetes with kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether using a real-time continuous glucose monitor (a device that tracks your blood sugar continuously) helps improve blood sugar control in people with type 2 diabetes who also have chronic kidney disease (stages 3 and 4). If you qualify, you may get better insight into your glucose patterns, which could help you manage your diabetes more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes with kidney disease (kidney function less than 60%) for at least 3 months.
- You are on insulin therapy (either long-acting or mealtime insulin) with or without other diabetes pills.
- You are not on dialysis and have not had a kidney transplant.
- You are able to manage a glucose monitoring device (no severe memory or thinking problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of tracking blood sugar in people with type 2 diabetes who use insulin. It aims to see if one method helps manage glucose better, which could improve daily control and long-term health.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This study tests whether a special type of insulin delivery system (closed-loop) can help people with type 2 diabetes and chronic kidney disease. You'll wear a continuous glucose monitor and insulin pump, and researchers will track how your kidneys respond over time.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.